Get the Stockscreener App
10.62
2.86%
0.295
Pre-market:
10.63
0.015
+0.14%
CorMedix Inc stock is traded at $10.62, with a volume of 2.14M.
It is up +2.86% in the last 24 hours and down -7.05% over the past month.
CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.
See More
Previous Close:
$10.32
Open:
$10.33
24h Volume:
2.14M
Relative Volume:
0.75
Market Cap:
$836.35M
Revenue:
$65,400
Net Income/Loss:
$-46.34M
P/E Ratio:
-11.54
EPS:
-0.92
Net Cash Flow:
$-38.74M
1W Performance:
+10.00%
1M Performance:
-7.05%
6M Performance:
-14.26%
1Y Performance:
+9.66%
1-Day Range:
$10.27
$10.76
1-Week Range:
$9.56
$10.76
52-Week Range:
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Name
CorMedix Inc
Sector
Industry
Phone
908-517-9500
Address
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
10.62 | 813.10M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Upgrade | D. Boral Capital | Hold → Buy |
| Jun-30-25 | Downgrade | D. Boral Capital | Buy → Hold |
| Jun-30-25 | Initiated | H.C. Wainwright | Buy |
| Mar-07-25 | Initiated | Leerink Partners | Outperform |
| Jan-13-25 | Initiated | D. Boral Capital | Buy |
| Aug-26-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-17-21 | Initiated | Needham | Buy |
| Sep-29-20 | Initiated | JMP Securities | Mkt Outperform |
| Sep-21-20 | Initiated | Truist | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Mar-26-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-06-18 | Initiated | ROTH Capital | Buy |
| Sep-25-17 | Reiterated | H.C. Wainwright | Buy |
| Aug-10-17 | Reiterated | Rodman & Renshaw | Buy |
| May-05-17 | Reiterated | Rodman & Renshaw | Buy |
| Nov-11-16 | Reiterated | FBR & Co. | Outperform |
| Mar-17-16 | Reiterated | FBR Capital | Outperform |
| Mar-03-16 | Initiated | FBR Capital | Outperform |
| Nov-16-15 | Reiterated | ROTH Capital | Neutral |
| Oct-29-15 | Reiterated | ROTH Capital | Neutral |
| May-06-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-08-14 | Reiterated | ROTH Capital | Buy |
| Oct-03-11 | Downgrade | Maxim Group | Buy → Hold |
View All
CorMedix Inc Stock (CRMD) Latest News
Is CorMedix Stock Still Attractive After Strong Multi Year Gains And Recent Volatility In 2025 - Yahoo Finance
CorMedix director Dillione sells $466k in shares - Investing.com
Is CorMedix (NASDAQ:CRMD) Using Too Much Debt? - 富途牛牛
How (CRMD) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Deep Track Capital, LP's Strategic Acquisition of Cormedix Inc Shares - GuruFocus
Will CorMedix Inc. (19KA) stock benefit from sector leadershipBuy Signal & Reliable Volume Spike Trade Alerts - Newser
Is CorMedix Inc. stock supported by innovation pipelineQuarterly Profit Report & Risk Managed Investment Entry Signals - Newser
Will CorMedix Inc. (19KA) stock see insider accumulationLong Setup & Accurate Entry/Exit Alerts - Newser
Should I buy CorMedix Inc. (19KA) stock before earnings seasonJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Can CorMedix Inc. stock sustain revenue growthWeekly Profit Summary & Consistent Return Investment Signals - Newser
Will CorMedix Inc. stock see PE expansionRate Cut & High Accuracy Trade Signal Alerts - Newser
Cormedix (CRMD) Stock Analysis Report | Financials & Insights - Benzinga
Is CorMedix Inc. stock a bargain at current levelsTrade Entry Report & Short-Term Trading Opportunity Alerts - Newser
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance - MSN
Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday - Sahm
CorMedix director Dillione sells $261,585 in CRMD stock By Investing.com - Investing.com Australia
At Cormedix, Janet Dillione Chooses To Exercise Options, Resulting In $158K - Benzinga
CorMedix director Dillione sells $261,585 in CRMD stock - Investing.com India
CorMedix Director Janet Dillione Sells 26,343 Shares - TradingView
Dir Dillione Sells 26,343 ($261.6K) Of CorMedix Inc [CRMD] - TradingView
CorMedix (CRMD) Is Down 6.3% After Strong Q3 Results and $87.6M Shelf Registration Filed - simplywall.st
What drives CorMedix Inc stock priceAnalyst Downgrades & Small Capital Trading Plans - earlytimes.in
Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? - Yahoo Finance
Dir Dillione Files To Sell 73,000 Of CorMedix Inc [CRMD] - TradingView
H.C. Wainwright Raises the PT on CorMedix Inc. (CRMD), Keeps a Buy - MSN
American Kidney Fund Hosts Third Patient Access Initiative Summit to Address Barriers to Kidney Care and Propose Innovative Solutions - GlobeNewswire Inc.
Will CorMedix Inc. (19KA) stock deliver compounding returns2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
How institutional buying supports CorMedix Inc. stockJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
Cormedix Inc (CRMD) Q3 2025 Earnings Call Highlights: Record Financial Performance and ... By GuruFocus - Investing.com Canada
Why CorMedix Inc. (19KA) stock attracts HNW investorsTrend Reversal & High Conviction Trade Alerts - newser.com
CorMedix Stock Hits Day Low of $9.82 Amid Price Pressure - Markets Mojo
How CorMedix Inc. (19KA) stock stacks up against competitorsJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
How big funds are accumulating CorMedix Inc. (19KA) stockPortfolio Performance Report & Real-Time Stock Movement Alerts - newser.com
How CorMedix Inc. stock performs in rising dollar environmentMarket Activity Report & Low Risk Entry Point Guides - newser.com
Will CorMedix Inc. stock benefit from green energy trendsJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Should I hold or sell CorMedix Inc. stock in 2025Market Trend Summary & AI Forecast Swing Trade Picks - newser.com
What institutional flow reveals about CorMedix Inc.Weekly Investment Summary & Low Risk Entry Point Guides - newser.com
Will CorMedix Inc. (19KA) stock outperform value peersMarket Movers & Real-Time Buy Zone Alerts - newser.com
Is CorMedix Inc. reversing from oversold territory2025 Performance Recap & Community Trade Idea Sharing - newser.com
Reversal indicators forming on CorMedix Inc. stock2025 Biggest Moves & AI Driven Stock Reports - newser.com
Is CorMedix Inc. stock positioned for digital transformationEarnings Overview Report & Reliable Entry Point Alerts - newser.com
CorMedix Inc Stock (CRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):